Adaptive Biotechnologies: A Separação da MRD Cria uma Empresa "Pure-Play" de Crescimento Composto (NASDAQ:ADPT)
· seekingalpha.com
Adaptive Biotechnologies (ADPT) muda o foco para diagnósticos de MRD "pure-play" à medida que a adoção do clonoSEQ, as margens e o backlog aumentam.
My current bullish outlook on Adaptive Biotechnologies Corporation ( ADPT ) stems from the economic and financial change in the business rather than the science...